Next-generation Sequencing Services Industry Size

The report "NGS Services Market Size by Type (Presequencing [Sample Prep, Quality Control], Sequencing [RNA, ChIP, Whole Genome], Bioinformatics), Workflow, Application (Diagnostics, Cancer, Drug Discovery, Pharmacogenomic), End User, Region - Global Forecast to 2031" The NGS Services Market is expected to reach USD 9.37 billion in 2031 from USD 3.96 billion in 2026, at a CAGR of 18.8% during the forecast period.  

Browse 593 market data Tables and 55 Figures spread through 436 Pages and in-depth TOC on "NGS Services Market Size by Type (Presequencing [Sample Prep, Quality Control], Sequencing [RNA, ChIP, Whole Genome], Bioinformatics), Workflow, Application (Diagnostics, Cancer, Drug Discovery, Pharmacogenomic), End User, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ngs-services-market-194102241.html

The NGS services market is experiencing strong growth, driven by the increasing outsourcing of sequencing workflows across clinical research, drug discovery, diagnostics, and population genomics. Pharmaceutical and biotechnology companies are expanding the use of whole-genome sequencing, exome and targeted sequencing, RNA sequencing, and other specialized sequencing services to support biomarker discovery, patient stratification, and therapeutic development. Growing adoption of long-read sequencing services and demand for customized NGS workflows are further supporting market expansion. Hospitals and clinical laboratories are also increasing the use of NGS services for cancer, infectious disease, and reproductive health applications. At the same time, service providers are strengthening bioinformatics, data visualization, interpretation, and data management capabilities to handle increasingly complex datasets. However, the market faces restraints such as declining benchtop sequencer costs and operational challenges related to turnaround time and capacity utilization. Managing, analyzing, and interpreting large volumes of NGS data also remain major challenges.

By type, the sequencing services segment held the largest share of the NGS services market in 2025.

By type, the NGS services market is segmented into presequencing services, sequencing services, bioinformatics & data analysis services, and NGS platform services. In 2025, sequencing services accounted for the largest market share. This is primarily due to the broad use of whole-genome sequencing, exome and targeted resequencing, RNA sequencing, de novo sequencing, ChIP sequencing, and methyl sequencing across clinical research and life science applications. Pharmaceutical and biotechnology companies increasingly outsource sequencing to access advanced platforms without making large capital investments. Hospitals and clinical laboratories also use these services for cancer diagnostics, infectious disease testing, and reproductive health applications. The need for specialized expertise, high-throughput capabilities, and reliable quality control further supports demand. Growing population genomics programs and wider use of NGS in drug discovery are also strengthening sequencing services' position in the market.

By workflow, the sequencing segment held the largest share of the NGS services market in 2025.

By workflow, the NGS services market is segmented into pre-sequencing, sequencing, and data analysis. In 2025, sequencing accounted for the largest market share. This is mainly due to the extensive use of sequencing workflows across whole-genome sequencing, exome and targeted sequencing, RNA sequencing, de novo sequencing, ChIP sequencing, and methyl sequencing. Sequencing represents the core revenue-generating stage of NGS service delivery and requires access to advanced platforms, skilled personnel, and high-throughput laboratory infrastructure. Pharmaceutical and biotechnology companies increasingly outsource this stage to support biomarker discovery, drug development, and translational research. Hospitals and clinical laboratories also rely on sequencing workflows for cancer, infectious disease, and reproductive health applications. Growing population genomics programs and rising demand for customized NGS studies further support the sequencing workflow segment's leading position.

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the NGS services market. This is supported by strong genomics research infrastructure, high adoption of outsourced sequencing workflows, substantial investment in precision medicine and drug development, and the presence of leading pharmaceutical and biotechnology companies, hospitals, clinical laboratories, and research institutes. The region also benefits from large-scale population genomics programs and increasing use of NGS in cancer diagnostics, infectious disease testing, and reproductive health applications. Growing demand for whole-genome sequencing, RNA sequencing, targeted sequencing, and advanced bioinformatics services continues to support market growth. Wider adoption of long-read sequencing and customized NGS services is further strengthening North America’s position in the global market.

Some of the leading players in the market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Eurofins Scientific (Luxembourg), Azenta US Inc. (US), BGI Group (China), Revvity (US), Agilent Technologies, Inc. (US), PacBio (US), Oxford Nanopore Technologies plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), and LGC Limited (UK), among others.

Don’t miss out on business opportunities in NGS Services Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]